Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Leuplin

 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

LeuprolideLeuprolide Acetate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Leuprorelin (Leuplin, Lupron, Viadur)
Leuplin is a drug for the treatment of prostate cancer. It is a sustained-release injectable formulation of leuprorelin acetate… Expand
Is this relevant?
2017
2017
Improved final predicted height with the injection of leuprolide in children with earlier puberty: A retrospective cohort study
The adult height of children with early onset puberty is limited by the premature maturation of hypothalamic-pituitary-gonadal… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2016
2016
Dose-finding study of Leuplin depot for prevention of premature luteinizing hormone surge during controlled ovarian stimulation: a pilot study in intrauterine insemination treatment.
OBJECTIVE The standard dose of depot gonadotropin releasing hormone agonist (GnRHa) may be too much to prevent premature… Expand
  • figure 1
  • figure 2
  • table 1
Is this relevant?
2007
2007
GnRH agonist acts as ovarian protection in chemotherapy induced gonadotoxicity: an experiment using a rat model.
To reduce chemotherapy induced gonadotoxicity, co-treatment with gonadotropin releasing hormone against analogue (GnRHa) was… Expand
  • table 1
  • figure 3
  • figure 1
  • figure 2
Is this relevant?
2006
2006
Skin Reactions to 3-month Depot Type of Luteinizing Hormone-Releasing Hormone Agonist Therapy
Objective Recently, skin reactions to luteinizing hormone-releasing hormone (LH-RH) agonist therapy were reported after the 3… Expand
  • table 1
  • table 3
Is this relevant?
2006
2006
Ultrasonographic evaluation of the change in uterine fibroids induced by treatment with a GnRH analog.
OBJECTIVE To investigate the change in volume of uterine fibroids after GnRH analog (GnRHa) treatment. MATERIALS AND METHODS… Expand
Is this relevant?
2003
2003
Involvement of calcitonin gene-related peptide in elevation of skin temperature in castrated male rats.
OBJECTIVES To assess the involvement of calcitonin gene-related peptide (CGRP) in the occurrence of hot flashes in men after… Expand
Is this relevant?
2003
2003
Enhanced polyadenosine diphosphate-ribosylation in gonadotropin-releasing hormone agonist-treated uterine leiomyoma.
This study aimed to examine the activation of poly(ADP-ribose) polymerase (PARP) and the accumulation of its end product, poly… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2002
2002
Fas and its ligand, caspases, and bcl-2 expression in gonadotropin-releasing hormone agonist-treated uterine leiomyoma.
GnRH agonist (GnRH-a) therapy is known to shrink uterine leiomyoma, although the molecular mechanisms responsible for this effect… Expand
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
Is this relevant?
2001
2001
[Clinical efficacy of leuprolide acetate and combined treatment with estramustine for advanced prostate cancer].
BACKGROUND/PURPOSE Twenty-two institutes have organized Keio University Prostate Cancer Study Group to study clinical efficacy… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE